Teleflex Incorporated Announces Quarterly Dividend of $0.34 (NYSE:TFX)

Key Points

• Teleflex declared a quarterly dividend of $0.34 per share, payable September 30 to shareholders of record on August 14. The annualized dividend is $1.36, yielding approximately 1.0%.
• The dividend appears well covered, with a current payout ratio of 9.7% and an expected future payout ratio of 12.9% based on projected earnings.
• Teleflex reported quarterly adjusted EPS of $1.76, beating estimates of $1.28, while revenue rose 28.9% year over year to $570.33 million. Its shares closed at $139.61, near the 52-week high of $145.00.

Teleflex Incorporated (NYSE:TFX - Get Free Report) announced a quarterly dividend on Thursday, August 6th. Investors of record on Friday, August 14th will be paid a dividend of 0.34 per share by the medical technology company on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th.

Teleflex has a dividend payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Teleflex to earn $10.55 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 12.9%.

Teleflex Price Performance

Teleflex stock traded up $2.83 during trading on Thursday, reaching $139.61. The company had a trading volume of 1,301,231 shares, compared to its average volume of 800,740. Teleflex has a 1-year low of $100.18 and a 1-year high of $145.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The firm's 50-day simple moving average is $131.41 and its 200 day simple moving average is $122.20. The firm has a market capitalization of $6.18 billion, a PE ratio of -6.12, a price-to-earnings-growth ratio of 1.04 and a beta of 0.81.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.28 by $0.48. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm had revenue of $570.33 million for the quarter, compared to analyst estimates of $559.59 million. During the same period in the previous year, the company posted $3.73 earnings per share. The business's revenue was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities research analysts anticipate that Teleflex will post 6.7 earnings per share for the current fiscal year.

Institutional Trading of Teleflex

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. AQR Capital Management LLC lifted its stake in shares of Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock valued at $287,603,000 after buying an additional 1,956,811 shares during the period. Irenic Capital Management LP purchased a new stake in Teleflex in the 1st quarter worth approximately $104,061,000. Norges Bank purchased a new stake in Teleflex in the 4th quarter worth approximately $66,076,000. Wolf Hill Capital Management LP acquired a new position in Teleflex in the 4th quarter valued at $47,405,000. Finally, Arrowstreet Capital Limited Partnership raised its holdings in Teleflex by 123.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company's stock valued at $80,855,000 after acquiring an additional 365,663 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source